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Hypertension is a serious chronic condition that afflicts many Americans. The present 
study used the Common Sense Model (CSM) of Self Regulation as a theoretical 
framework to aid in the examination of predictors of medication and/or lifestyle 
adherence. Based upon the literature reviewed, the current study proposes that predictors 
would be different for medication and lifestyle adherence. Three hypotheses were 
proposed: 1. CSM-related variables (blood pressure monitoring, condition-worry 
hypertension duration, control beliefs, and medication beliefs items) would be correlated 
with medication adherence; 2. specific CSM-related variables, self assessed health (SAH) 
and physical functioning would significantly be correlated with lifestyle adherence; 3. If 
there are common predictors of medication and lifestyle adherence, the predictors would 
account for more of one type of adherence than the other. The current study utilized data 
from a larger study evaluating patients’ management of acute and chronic conditions. 
Results supported the three hypotheses. There was no correlation between medication and 
lifestyle adherence. The overall model was significant in a stepwise regression with all 
CSM-related predictors, including age, race and education predicting medication 
adherence. The stepwise regression model was significant with all CSM-related 
predictors, including, age, race and education predicting lifestyle adherence. Different 
predictors in medication (the side effect of this treatment are manageable for me”) and 
lifestyle adherence (“the prescribed treatment for my hypertension keeps it under good 
control” were found supporting hypothesized independence of the two constructs.
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Introduction
Hypertension, commonly referred to as high blood pressure, is a serious chronic 
illness that is pervasive in American society. One in three adults in the United States has 
high blood pressure (American Heart Association, 2008), and epidemiological research 
indicates that hypertension may affect 90% of individuals during their lifetime (Wand & 
Vasan, 2005). It is also a condition which is very likely to be co-morbid with other 
illnesses; in addition, it is a disease that has behavioral and physiological connections to 
other health problems (American Heart Association, 2008). Individuals with hypertension 
are at a greater risk than those without hypertension for renal failure, heart attacks, and 
strokes (Wang & Vasan, 2005). Conversely, controlling hypertension has been shown to 
reduce risk of stroke and congestive heart failure (Appel, Brands, Daniels, Karanja,
Elmer, & Sacks, 2006). As individuals age, the incidence of hypertension continues to 
rise (65.4% of individuals 60 years of age or older (Hajjar & Kotchen, 2003).
Treatment of hypertension
The treatment of hypertension typically encompasses two approaches: 
drug/medication therapy and lifestyle approaches (e.g. diet, exercise, and other). The goal 
of treatment is often not to cure but instead to reduce blood pressure so that patients have 
a lower possibility of developing complications. What is important to note is that clinical 
recommendations for disease management is multi-faceted encompassing both 
medication and lifestyle behaviors. The National Heart, Lung and Blood Association has 
recommended that patients diagnosed with hypertension should work with their 
physicians in developing individualized blood pressure goals through lifestyle and 
medications regimens based upon individual risk factors. Lifestyle changes include
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exercise and healthier eating habits, such as diet, reduced sodium intake, reduced caloric 
intake, and weight loss. Medication protocols for those with hypertension often include 
one or more of a number of medicines such as alpha blockers, beta-blockers, calcium 
channel blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin 
receptor blockers (ARBs), Central alpha agonists, diuretics, Renin inhibitors and 
Vasodilators (High blood pressure treatment, lifestyle, medication, DASH diet. n.d.).
Adherence to hypertension treatment has however been problematic for many 
patients (Meyer, Leventhal, & Gutmann, 1985). This can be attributed to hypertension 
being a disease which is often asymptomatic and the treatments (especially medications) 
may make patients feel worse than the disease itself (Morrell et al, 1997; Chapman, 
Brewer, Coups, Leventhal, & Leventhal, 2001). While adherence may be difficult for 
some, individuals who have been able to satisfactorily control their blood pressure 
through a combination of a healthy lifestyle and medication have been able to, with 
doctor supervision and monitoring, step down or even withdraw from medications. The 
most successful at this endeavor are those individuals who have managed to maintain 
lifestyle changes (e.g., lose weight, reduce sodium intake), those who have had mono 
drug therapy (e.g., as opposed to combined medications) and those who have been able 
to maintain lower systolic blood pressure over the course of multi-faceted treatment 
(High blood pressure treatment, lifestyle, medication, DASH diet., n.d.).
Due to the scope and pervasiveness of hypertension it is a disease that has been 
the subject of considerable research. In a community-based cross-sectional survey in 
Ontario, Canada, 21% of individuals surveyed had hypertension (total adult population 
was 7,996,653) (Fodor, Mclnnis, Helis, Turton, Frans, & Leenen, 2009). Fodor and
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colleagues (2009) found that 42% of hypertensive patients were on antihypertensive 
medications and practiced lifestyle changes while 41% received drug therapy only. 
Controlled blood pressure was found in 85% of those who only were on drug therapy and 
78% of patients on the combination of drug and lifestyle treatments. There was not a 
significant difference between blood pressure and treatment modality (medication only 
versus medication plus lifestyle treatments). The researchers suggest that lifestyle 
changes are disappointing in “real life” when comparing to medication treatment (p. 34). 
An important limitation to this study was that self report was used to determine lifestyle 
changes and medication adherence. Interestingly, less than half of the hypertension 
patients who responded to the survey practiced lifestyle changes in addition to their 
regular medications.
Although Fodor and colleagues (2006) suggest that the combination of 
medication and lifestyle treatments are not as effective as medication alone, the limitation 
of the study may point to why these results occurred. Moreover, the findings from Fodor 
and colleagues contradict what is recommended by the National Heart, Lung and Blood 
Institute (i.e. High blood pressure treatment, lifestyle, medication, DASH diet, n.d.) 
which points out that it is important to look at hypertension treatment, in terms of both 
drug therapy and lifestyle treatments. If practitioners, researchers, patients and other 
stakeholders are to truly understand treatment regimens for high blood pressure, it is 
critical to evaluate the extent to which medication and lifestyle adherence has been 
studied in order to gain a comprehensive picture of how patients’ beliefs relate to 
adherence. Research has looked at factors involved in medication adherence in 
hypertensive patients (Haynes, Ackloo, Sahota, McDonald, Yao, 2008). Additionally,
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research has also looked at the factors involved in adherence to non-medication 
treatments such as dietary regimens, exercise regimens, or physical therapy (lifestyle 
treatments) (Whelton, Chin, Xin, & He, 2002). Research has investigated interventions 
that address both medication and lifestyle adherence simultaneously in order to improve 
blood pressure (Fahey, Schroeder, & Ebrahim, 2006). Due to the importance of lifestyle 
and medication adherence concurrently, the evaluation of factors that relate to either 
medication or lifestyle adherence is important.
Adherence to treatment for hypertension
There are a number of social factors that have been correlated with the incidence 
and prevalence of hypertension. The rates of high blood pressure are alarmingly high 
among African Americans, pursuant to the American Heart Association, almost one-third 
(31.2%) of all African American adults have high blood pressure. As a result of these 
elevated rates, researchers who look at adherence have sought to focus on culturally 
appropriate interventions that may increase adherence to hypertension treatment 
(medication and lifestyle changes). While taking into account cultural issues, Haafkens 
and colleagues’ (2009) study protocol is useful because it aids in the understanding how 
interventions address both medication and lifestyle adherence. Haafkens and colleagues 
(2009) have developed a study protocol to address more specifically the disparities found 
with individuals of African descent (in Europe) in controlling hypertension. The proposed 
interventions compare the standard Dutch clinical guidelines to a culturally-appropriate 
hypertension education in which elicitation and discussion of patients’ perceptions of 
hypertension and treatment will be encouraged, however the findings from this proposed 
program are not yet published. This study is important to note, not only because of the
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focus on cultural and race/ethnicity disparities, but because of its holistic approach to 
hypertension treatment, and the inclusion of both medication and lifestyle change.
Expanding on this notion that the two types of treatments should be examined 
together, the present study will look at factors/predictors involved in both medication and 
lifestyle treatment adherence. As previously stated, simultaneous investigation is 
important because adherence to both types of treatment is critical for controlling 
hypertension. It is possible, for example, that some individuals adhere to one type of 
treatment but not the other (e.g. Individuals who only take their medications and are non­
adherent to their lifestyle changes); without simultaneous measurement of both types of 
treatment, researchers will not be able to understand these individuals and the factors 
involved in their behavior accurately. If medication and lifestyle treatment adherence are 
distinct constructs, which factors determine one versus the other? If some patients are 
adherent to both medication and lifestyle treatments, what makes these patients different 
from patients who are non-adherent to either or both forms of treatment?
To begin, the important factors known to be involved in non-adherence to 
medication and to lifestyle treatments will be reviewed before discussing how these 
factors may be similar or different to each other and how they may interact to predict 
adherence. Adherence rates are lower for chronic conditions, such as hypertension, than 
for acute conditions (Osterberg & Blaschke, 2005). Patients who report missing any dose 
of their medication for their chronic conditions are non-adherent 60% of the time 
(Haynes, McDonald, & Garg, 2002). Thus, when a patient admits to missing any doses of 
their medication, the health professional can be confident that they are missing more than 
half the doses of the medication. Morrell and colleagues (1997) showed that 30-50% of
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hypertensive patients are non-adherent in taking their medications with some patients 
taking less and some taking more of their medications than prescribed.
Other factors known to affect medication adherence include an individual’s age 
(Morrell, Park, Kidder, & Martin, 1997), the asymptomatic nature of hypertension which 
hinders the patient from being able to see improvement with treatment (Meyer, 
Leventhal, & Gutmann, 1985), and the fact that the treatment can sometimes cause side 
effects (Chapman, Brewer, Coups, Leventhal, & Leventhal, 2001). Conversely, a 
positive predictor of medication adherence is how often the patient uses a blood-pressure 
monitor which is additionally associated with more active self-care in general (Feldman, 
Bacher, Campbell, Drover, & Chockalingam, 1998). The relationship of monitoring 
behavior to medication adherence may be due to a general healthy lifestyle; alternatively, 
the relationship between monitoring behavior and adherence may be specific to particular 
medications and not related to lifestyle treatments. However, the question remains, do 
those who monitor their hypertension also adhere to lifestyle treatments?
Low adherence is problematic not only when considering medication 
management but also when considering lifestyle changes. It has proven to be challenging 
for patients to stick to lifestyle treatments. Diet and exercise adherence have a 
relationship with obesity and high blood pressure (Appel, Brands, Daniels, Karanja, 
Elmer, & Sacks, 2006); therefore, adherence to diet and exercise can address 
hypertension more fully than blood pressure medication alone. However, adherence to 
diet and exercise regimen is poor (Leventhal, Dienfenbach, & Leventhal, 1992).
Many reasons for individuals not adhering to exercise and diet plans are well 
documented and include intention-behavior gap, preference reversals, conservation of
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energy in the elderly, and ratings of self assessed health. More specifically, non­
adherence to lifestyle treatments may be a result of the “gap” between individuals’ 
behavioral intentions and their actual behavior (“intention—behavior gap”; Sniehotta, 
Scholz, & Schwarzer, 2005). Additionally, individuals reverse their preference for a 
behavior when it comes time to perform it. For example, an individual may decide that 
after indulging in an evening treat to run five miles the following day at 6 am. However, 
when the alarm goes off, the individual reverses his/her preference (running) for the 
snooze button. The above example demonstrates how challenging it is to effectively alter 
one’s behavior (“preference reversals”; Bems, Laibson, & Loewenstein, 2007).
Specifically, with regard to elderly patients with hypertension, Duke and 
colleagues (2002) found that patients may limit their activities above and beyond their 
illness severity. A loss of activities was predicted by both chronic conditions, illness and 
age severity. That is some patients reduce their activities beyond their physical 
limitations which adversely affects their physical health. However, patients who had 
social support, were optimistic and had less of a need to conserve energy were more 
likely to replace lost activities. Leventhal and colleagues (1993) proposed that patients 
who limit their activities may do so in order to conserve energy resources. Thus, when 
considering the complexities underlining adherence to lifestyle treatments one should 
consider an individual’s inclination to reverse their preference for a health behavior (diet 
and/or exercise). Additionally, elderly patients may have a desire to decrease physical 
activities as a function of needing to conserve energy.
Lower ratings of self-assessed health are predictive of less activity, and 
individuals with hypertension and other chronic illness rate themselves lower in general
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health (Idler, Leventhal, McLaughlin, & Leventhal, 2004). Patients who are low in 
physical functioning and/or who rate themselves low in general health may not be 
adherent to their lifestyle regimen because of the need to conserve energy. However, 
patients who are low in physical functioning and either unable or unwilling to adhere to 
their lifestyle treatments may also not adhere to their medical treatment.
Research has looked at interventions that promote lifestyle modifications. Scala 
and colleagues (2008) used a motivational approach compared to a control group to 
control blood pressure, in a twelve month follow up study. The motivational group 
(Intervention group) participated in a focus group at 2 months and 4 months post 
recruitment. The control group received only oral information. Additionally, the control 
group was called two and four months after recruitment so that the clinical staff could 
obtain blood pressure, heart rate and weight in order to compare them with the 
intervention group. Both groups had their blood pressure recorded and “drug therapy 
registered” pre intervention and 12 months post intervention (p. 836). Although, this 
study is not a direct assessment of medication adherence it suggests that assessing one’s 
beliefs as they relate to lifestyle changes and being a part of a group increases lifestyle 
modification and thus improves blood pressure.
The Common Sense Model of Health Beliefs and Behavior
The Common Sense Model (CSM) of health beliefs and behavior, first proposed 
by Leventhal, is a useful theoretical framework that can support the investigation of 
factors that influence adherence to medication and lifestyle treatments (Leventhal, 
Dienfenbach, & Leventhal, 1992; Leventhal, Brissette, & Leventhal, 2003). The CSM is 
a multidimensional framework that takes into account health beliefs, emotionality, and
14
cognition, which aids in the understanding of patients’ health beliefs and behaviors and 
has been applied to patients with varying chronic diseases (Hale, Trehame, & Kitas, 
2007) including hypertension (Hekler, Lambert, Leventhal, Leventhal, Jahn, & Contrada, 
2008; de Ridder, Theunissen, & van Dulmen, 2007). Patients develop illness 
representations or “common sense” beliefs about their illness and treatment from both 
abstract/factual (such as from the medical provider) and experience-based information 
(such as changes in symptoms, e.g., with stress); the CSM places these beliefs into five 
domains: identity, cause, duration, consequence, and cure.
Identity refers to the symptom experience and the name of the condition 
(hypertension, flu, etc). Cause is what the patient believes to be the basis of the condition 
(intemal/genetic and/or extemal/environmental causes). Timeline or duration connotes 
the temporal expectation of the disease, simply how long one can expect to have the 
condition (i.e. Will I have hypertension for the rest of my life?). Consequence is the 
expected outcome of what the condition means (what the condition means for me in the 
long term-1 must watch my salt and take medicine every day). Lastly, the cure domain 
assesses patient’s beliefs whether the treatment regimens will alleviate the condition. 
Patients’ illness representations or CSMs are fluid in that they change with new 
information and new experiences, which in turn affect their health behaviors (for a review 
see Ogden, 2000).
The CSM has been used as a theoretical framework in evaluating adherence in 
hypertensive patients. Based upon abstract and factual/experiential information the CSM 
has shown how patients’ manage their condition at different stages in treatment. More 
specifically, Meyer and colleagues (1985) interviewed patients at different stages in their
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diagnosis of hypertension. 65% of the patients were only on a diuretic for their treatment, 
60% of the patients were African American and 55% were female. Four groups were 
interviewed. The first group served as a control because they were visiting the doctor for 
a reason other than blood pressure (“normotensive clinic controls”). The second group 
was labeled the “newly treated” group and was at the clinic for the first time for the 
treatment of their hypertension. Third group, labeled “continuing treatment” had been in 
continuous treatment from three months to fifteen years. Lastly, the “re-entry” group had 
previously discontinued treatment and had returned to treatment. Patients’ beliefs were 
elicited in a 45-minute structured interview and an open ended question to better 
ascertain the patients’ beliefs compared to generally accepted views (what they thought 
they should say). Results suggest that patients in the “new to treatment” group were more 
likely to discontinue treatment if they indicated they experienced symptoms and told the 
doctor on their first visit in addition to believing their hypertension to be an acute 
condition. Patients in the “continuing treatment” group were more likely to stay in 
treatment if they believed their symptoms to be controlled. These patients also were more 
compliant to medication treatment and were more likely to have controlled blood 
pressure.
Leventhal and colleagues have illustrated that common-sense beliefs are related to 
medication adherence in hypertensive patients. Hekler and colleagues (2008) 
demonstrated in a sample of African American patients with hypertension that there are 
two prototypical common-sense models endorsed that affect patients’ adherence 
behaviors. Endorsement of a “medical belief model” of hypertension showed that patients 
believed the disease to be caused and controlled by diet, exercise, age, and weight. The
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second is the “stress belief model” in which patients endorse the belief that stress is the 
main contributor (control and cause) of their hypertension. The stress belief model 
demonstrates how the CSM has effectively identified a maladaptive strategy in 
understanding one’s illness. While, chronic stress can be a contributing factor in the 
cause of hypertension or exacerbate the illness, (American Institute of Stress, n.d.) it is 
not the sole cause.
The notion that stress is a single cause has been shown to have important 
consequences for patients’ adherence. This is demonstrated in Hekler et al (2008) who 
found that endorsement of the “medical belief model” was associated with lower systolic 
blood pressure and was mediated by lifestyle behaviors. Stress reduction was not 
associated with systolic blood pressure. Endorsing the “stress belief model” led to 
behaviors that decreased stress which did not lead to medication or lifestyle changes. 
Heckler et al. (2008) also found evidence that CSM-related factors may predict different 
kinds of adherence. Heckler and colleagues’ findings suggest that lifestyle and 
medication adherence are different constructs and factors involved in each types of 
adherence may be different from each other. It is here that the present study seeks to 
expand the literature on hypertension treatment adherence and will explicitly evaluate the 
extent to which medication adherence and lifestyle adherence are distinct constructs. 
Additionally, this study will evaluate hypertension beliefs in a more representative 
sample. Moreover, the current study will appraise the extent to which CSM beliefs are 
associated to both lifestyle and medication adherence, respectively.
As previously stated, stress is not considered to be the sole cause of hypertension. 
That is not to say developing effective coping skills to aid in the management of stress
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does not positively affect patient outcomes. Dusek and colleagues (2008) conducted a 
double-blind, randomized trial comparing stress management to lifestyle modification. 
The outcome variables were medication elimination and systolic blood pressure at eight 
weeks. Results suggest that the stress management group led to more elimination of their 
antihypertensive medication. Both groups had a reduction in systolic blood pressure, 
however, patients in the stress management group were significantly more likely 
eliminated antihypertensive medications The researchers address an important limitation 
in the present study that the antihypertensive medications that patients reported being on 
were not standardized. Thus patients who were on a certain type of medication may have 
been able to eliminate said medication easier compared to a different type of medication. 
Results point to the importance of providing patients with skills that will allow them to 
cope with stress (i.e. mindful meditation, etc) and their chronic conditions while 
effectively communicating the importance of lifestyle changes.
In understanding patient adherence, the evaluations of patient beliefs is critical. 
Leventhal and Cameron (1987) proposed that adherence is a function of the patient’s 
belief about their medication. They posit that a patient who believes he/she lacks control 
over his/her illness will be less adherent because taking medication would have little 
effect on his/her disease outcome. Treatment efficacy belief is a strong predictor of 
adherence (DiMatteo, 2003).
As indicated above, the current study will look at both medication and lifestyle 
adherence. Research has evaluated medication adherence and specific CSM-related 
beliefs. Research has looked at CSM-related factor that may predict adherence based 
upon Medical or Stress Belief Model (Hekler et al, 2008). I will expand upon this
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literature by further looking at functional limitations, self-assessed health, monitoring 
behavior, and CSM-related beliefs (e.g., “I will have hypertension for the rest of my life” 
and “The cause of my hypertension is clear to me”) as they relate to medication and 
lifestyle treatment adherence. Factors related to medication and lifestyle treatment 
adherence behaviors will be evaluated separately and compared to each other in order to 
assess how the factors influence each type of adherence are related.
Based on the CSM model, three hypotheses have been formulated. The first 
hypothesis is that the ten specific CSM-related variables (Appendix 1) will be 
significantly related to medication adherence. The second hypothesis is specific CSM- 
related variables (self assessed health and physical function) will be significantly related 
to lifestyle adherence. Hypothesis three is that if there are common predictors to 
medication and lifestyle adherence, the predictors will account for more of one type of 
adherence versus the other. Due to the exploratory nature of this study, stepwise 
regression will be done on all of the predictors including age, race, and education on the 
criterion variables (lifestyle and medicine adherence) in separate analysis.
Methods
Participants and Recruitment
The present study is based on a larger study that was conducted between the summer 
of 2007 to the winter of 2008 in an internal medicine primary care practice at a university 
medical center. All patients who were seeing a physician in the primary care practice 
were approached by research personnel regardless of their reason for seeing their doctor.
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Of those approached, 56 percent volunteered to participate and completed informed 
consent forms. There were 402 patients who agreed to participate. Of the 402 patients 
recruited for the larger study 129 were diagnosed with hypertension. 105 patients were 
prescribed both medication and lifestyle regimens for their hypertension. Informed 
consent and consent forms were completed and obtained prior to each patient’s doctor 
visit. Patients who were recruited a second time were excluded.
The current study had 105 hypertensive patients with a mean age of 66.68 (table 2). 
64.8% were female and 49.5% had less than or equal to a two year degree (associate 
degree). 54.3% were retired and 28.6% were working full time. 37.5% had private health 
insurance/HMO while 46.2% had Medicare with supplemental insurance. A majority of 
the sample were married (69.5%) and white/European American (73.1%).
Measures
As part of the protocol for the larger study, the following variables of interest were 
included in the current study: CSM-related beliefs including self-assessed health (SAH); 
physical functioning; condition-worry, timeline, control belief, monitoring behavior, as 
well as 4 medication belief items (“the prescribed treatment for my hypertension/high 
blood pressure keeps it under control”, “I can actually feel the medicines working in my 
body”, “the side effects of this treatment are manageable for me”, “I have a good idea of 
how the medicines work”; and also lifestyle and medication adherence).
The predictor variables were SAH, physical functioning, condition-worry, timeline, 
control beliefs, monitoring behavior, and the four CSM medication items. Criterion 
variables were medication adherence and lifestyle adherence. Details describing all of 
these measures are presented in Appendix 1.
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Criterion variables.
Both lifestyle and medication adherence were assessed using the Medication 
Adherence Report Scale (MARS), (Thompson, Kulkami, & Sergejew, 2000). The 
medication adherence question was: “Do you ever accidently forget to use one of your 
medicines?”. This question was a Likert scale item with possible answer choices: never, 
rarely, sometimes, often, or always. Lifestyle adherence was assessed using the item 
worded: “Do you ever accidentally forget to do one of your other treatments (diet, 
exercise, or others)?”. The scaling was the same as for Medication Adherence: “never”, 
“rarely”, “sometimes”, “often”, and “always”.
Predictor variables.
Self-assessed health (S AH) was assessed by the item “In general, would you say your 
health is...” with possible answer choices “poor,” “fair,” “good,” “very good,” 
“excellent.” Physical functioning is a composite variable from patients’ responses to two 
items from the Short Form 12 item survey (SF-12) (Ware, Kosinski, & Keller, 1996). 
’’Does your health now limit you in moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf?" and “Does your health now limit you in 
climbing several flights of stairs?”. The possible answer choice to both items was: “yes, 
limited a lot,” “yes, limited a little,” or “no, not limited at all.” A value of 1 was given to 
“yes, limited a lot,” 2 was assigned to “yes, limited a little” and 3 was assigned to “no, 
not limited at all.” The values were assigned to both items. The range of scores was 
between 2 and 6, with higher numbers corresponding to higher level of physical 
functioning (fewer limitations). (Appendix 1)
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Several other CSM-related belief items used in the current study were Likert scale 
items (Appendix 1). Specifically, timeline belief was assessed using: “I will have HBP 
for the rest of my life”; Control belief: “My HBP is under control most or all of the 
time”; Condition-worry “How worried or concerned are you about you HBP?”. These 
items had a possible answer choice of “not at all,” “a little bit,” “somewhat,” “quite a 
bit,” or “very much.” Monitoring behavior was assessed with “How often do you use a 
monitor or instrument to keep track of your Hypertension/High Blood Pressure?” and the 
possible answer choices were “not at all,” “less than once a month,” “monthly,” “weekly 
(1-2 times/week),” 2-3 times/week,” or “daily.”
Medication belief questions were: “The prescribed treatment for my 
Hypertension/High Blood Pressure keeps it under good control,” “I can actually feel the 
medicines working in my body,” “The side effects of this treatment are manageable for 
me,” and “I have a good idea how the medicines work.” These items had a possible 
answer choice of “not at all,” “a little bit,” “somewhat,” “quite a bit,” or “very much.” 
Lastly, self-assessed health (SAH) was assessed by the item “In general, would you say 
your health is...” with possible answer choices “poor,” “fair,” “good,” “very good,” 
“excellent.”
Age and education are continuous variables. Race was defined as White/European 
American and Minorities. This split was done because majority of the sample (73.1%) 
identified themselves as White (Table 2). Education and age was defined in years. 
Procedure
After the consent forms were completed, patients filled out a one-page questionnaire 
while waiting to be called in for their appointment. Items that were assessed included the
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reason for the visit, self-assessed health (SAH), and what they expected from the doctor 
visit. Patients separately consented to have their doctor visit audio-recorded. If the 
patients did not consent to have their visit audio-recorded they were still included in the 
study. After the patient was called into the physician’s office a questionnaire was given to 
the physician that was to be filled out by the physician following the visit. The 
physician’s questionnaire assessed patient’s health, illness progression, and prescribed 
treatments. Patients were then contacted 24-48 hours after their doctor visit for a 1.5 to 2 
hour phone interview. The interview consisted of assessment of doctor prescribed 
treatment plans, physical and mental functioning, general health appraisals, and the 
patient’s common-sense model beliefs. One month after the 24-48 hour interview patients 
were contacted again by research personnel for a 30 minute phone interview. This phone 
interview consisted of assessment about presenting problem resolution, physical and 
mental functioning, general health assessment, and adherence to the presenting problem 
prescribed treatments.
All research personnel interviewers went through training prior to recruiting and 
interviewing. Additionally, interviewers had bi-weekly meetings to assess progress and to 
keep up with the training and protocols.
Analysis overview
In order to explore the relationships between the predictor and criterion variables, 
bivariate Pearson product moment correlations were computed for all 10 CSM related 
variables and the two criteria measures.
The first two hypotheses (The first hypothesis is that the ten specific CSM-related 
variables (Appendix 1) will be significantly related to medication adherence. The second
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hypothesis is specific CSM-related variables (self assessed health and physical function) 
will be significantly related to lifestyle adherence.) were tested using bivariate Pearson 
correlations using SPSS 16. The predictors and criteria used in the analyses are 
continuous variables. A bivariate Pearson product-moment correlation coefficient was 
computed to assess the relationship between the 10 CSM predictors (SAH, physical 
functioning, monitoring; condition-worry; timeline; control belief; 4 medication belief 
items) and medication adherence (Hypothesis one). Additionally, bivariate Pearson 
product-moment correlation coefficients were computed to assess the relationship 
between two predictors (self-assessed health (SAH) and physical functioning (specific 
physical abilities)) and lifestyle adherence (Hypothesis two).
To further explore the relationship between the predictors and the criterion variables, two 
separate stepwise regression analyses were conducted using all of the CSM-related 
predictors (Appendix 1), plus age, race, and education. The criteria were medication 
adherence and lifestyle adherence, respectively.
Expected results
Expected results are shown on Table 1 and are for the bivariate correlations 
(hypotheses one and two). Plus sign (+) indicates a positive relationship. For example, 
individuals who use a blood pressure cuff will be more likely to be adherence to their 
medications. Since this is a preliminary analysis specific predictions on lifestyle 
adherence are only made for SAH and physical functioning. The other predictors have a 
question mark (?) indicating that there is no specific predictions made that can be 
supported by the existing literature or CSM theory. The results for the subsequent
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analysis will depend on the findings of the bivariate analysis therefore no particular 
results are expected.
Results
The results of the correlation analysis between CSM-related predictors and 
medication adherence are presented in Table 3. A significant positive relationship was 
shown between “The side effects of this treatment are manageable for me” and 
medication adherence r(95) = .232, p<.05. As hypothesized, patients who indicated they 
were able to manage the side effects of their treatments were more likely to adhere to 
their medications. No other correlations were found to be significant (Table 3) with 
medication adherence.
To test hypothesis two, Pearson correlation was used to examine the relationship 
between SAH as well as physical functioning and lifestyle adherence (Table 3). A 
significant positive correlation was shown between SAH and lifestyle adherence r (103)= 
.222, p<.05. As hypothesized, patients who rated their health higher were more likely to 
adhere to their lifestyle treatments. Contrary to hypothesis two, a significant relationship 
was not found between physical functioning and lifestyle adherence r(103)= .024, p=.81. 
In addition, two non-hypothesized relationships were found. A significant negative 
relationship was revealed between condition-worry and lifestyle adherence r(102)= -.197, 
p<.05. Patients who worry about their hypertension were less adherent to their lifestyle 
treatments. Furthermore, a significant positive relationship was found between the 
medication belief item, “The prescribed treatment for my Hypertension/High Blood 
Pressure keeps it under good control” and lifestyle adherence r(101 )= .224, p<.05.
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Patients’ beliefs that their treatment keeps their hypertension under good control are more 
likely to be adherent to lifestyle treatments.
Hypothesis three was tested by examining the pattern of correlations between the 
10 CSM related predictors and the two outcome variables (see Table 3). These 
correlations showed that there were four variables that predicted either medication or 
lifestyle adherence. Only one of the medication belief items was significantly related to 
medication adherence. The correlation between “side effects of this treatment are 
manageable for me”, and medication adherence (r(95)= .232, p<.05) was significant. For 
lifestyle adherence, Self-Assessed Health, condition-worry and one medication belief 
item (“the prescribed treatment for my hypertension keeps it under good control”) were 
significantly correlated (r(103)=.222, r=(102)= -.197, r=(101)=.224, respectively; p<.05 
for all correlations). This pattern of results indicates that there are no shared predictors 
between the 10 CSM beliefs and the two adherence variables. In addition, the pattern of 
correlations for each of the adherence variables is different from one another.
Finally, Pearson product moment correlation was used to evaluate the relationship 
between lifestyle and medication adherence. This analysis revealed that there is no 
significant correlation between medication adherence and lifestyle adherence 
r(103)=.056, p=.572.
Stepwise regression analysis was done with medication and lifestyle adherence as 
the criterion, in separate analyses. Due to the exploratory nature of this analysis, all 
predictors including age, race, and education were entered into a stepwise regression 
simultaneously. Moreover, a less stringent alpha (.05-. 11) was set in order to allow the 
predictors to account for more of the variance. Results indicate that the overall model was
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significant in predicting medication adherence F(l,76)=5.368, p<.05. A summary of the 
regression coefficients are presented in table 4 and shows that only one item (“The side 
effects of this treatment are manageable for me”) of the ten CSM-related predictors 
significantly contributed to the model. This model accounts for 6.6% of the variance. 
Table 4.1 shows the predictors that were not significant to the overall model. However, 
physical function showed a trend toward significance, p=.057.
The same analysis (stepwise regression) was conducted with lifestyle adherence 
as the criterion. The overall model was significant F(l,76)=4.707, p<.05 and accounted 
for 5.8% of the variance. A summary of the regression coefficients are presented in table 
5 and shows that one item (“The prescribed treatment for my hypertension keeps it under 
good control”) out of the ten CSM-related predictors significantly contributed to the 
model. Item, “I have a good idea of how the medicines work” showed a trend toward 
significance, p=.059. Table 5.1 shows the predictors that were not significant to the 
overall model.
Discussion
This study was designed to evaluate the relationship between CSM-related 
predictors and medication as well as lifestyle adherence, respectively. Three hypotheses 
were tested. Hypothesis one was not well supported by the significant correlation 
between the predictor “The side effects of this treatment are manageable for me” and 
medication adherence (Table 3). Monitoring behavior (using a blood pressure cuff), 
physical functioning, condition-worry, hypertension duration beliefs, hypertension 
control belief, in addition to the other medication belief items (“The prescribed treatment 
for my Hypertension/High Blood Pressure keeps it under good control;” “I can actually
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feel the medicines working in my body;” “I have a good idea how the medicines work”) 
did not correlate with medication adherence. There are a number of reasons why my 
results were not supported which will be addressed in the limitations and further direction 
section.
Hypothesis two was narrowly supported with a significant positive relationship 
between SAH and lifestyle adherence. Contrary to my hypothesis, physical functioning 
did not significantly correlate with lifestyle adherence. A significant negative relationship 
was found between condition-worry and lifestyle adherence. Although this may be, on 
initial reflection, counterintuitive, this correlation actually suggests that individuals who 
do not adhere to their lifestyle treatments worry more about their hypertension. Patients 
who do worry about their condition would presumably be more likely to adhere to both 
medication and lifestyle treatments. Nevertheless, this relationship points to an interesting 
issue, in so much that individuals who adhere to their prescribed medications but not their 
lifestyle treatments may worry because they are cognizant of the discrepancy. Patients 
may worry about their hypertension which may reflect non-adherence in both medication 
and lifestyle adherence, although this is not supported by this study. Additionally, 
lifestyle adherence is particularly low because of the required behavioral change which 
many find to be a challenge for a variety of reasons including preference reversals and 
intention-behavior gap (Bems, Laibson & Loewenstein, 2007 and Sniehotta, Scholz & 
Schwarzer, 2005). Perhaps worrying about one’s condition is an extension that the patient 
is mindful of the fact that they are not adhering to their lifestyle treatments.
A significant positive relationship was revealed between prescribed control-treatment 
belief (“The prescribed treatment for my Hypertension/High Blood Pressure keeps it
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under good control”) and lifestyle adherence. That is patients who believe the prescribed 
treatment keeps their hypertension under control are more likely to adhere to their 
lifestyle treatments. This correlation makes sense when considering that treatment 
efficacy belief is a strong predictor of adherence (DiMatteo, 2003). If a patient believes 
the treatment is effective than they are more likely to adhere.
Medication and lifestyle adherence did not correlate with each other. This has 
important implications for physicians. Patient adherence to medication or lifestyle 
treatments do not predict adherence to the respective other type of treatment. As Haynes 
et al (2005) demonstrates patients who admit to missing any dose of their medications for 
their chronic conditions of their non-adherent 60% of the time. What does this look like 
for patients in terms of lifestyle adherence? Further research is needed to tease out the 
extent to which patients differ in their medication and lifestyle adherence. This has 
important implications for physicians and health care providers as adherence between 
medication and lifestyle are not related, based upon this study. Thus, if a patient adheres 
to his/her medications, they may or may not be adherent to their lifestyle treatments.
The third hypothesis, which asserted that if there are common predictors to 
medication and lifestyle adherence, the predictors would account for more of one type of 
adherence versus the other was not confirmed. Since there were no shared predictors 
between medication and lifestyle adherence, the hypothesis was supported lending 
support that medication and lifestyle adherence predictors are distinct. What predicts one 
type of adherence may not predict the other type of adherence. Further research 
evaluating additional predictors would be useful. The current study still leaves open the 
question that there may be shared predictors that were not assessed in the present study.
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Thus, there are in fact shared predictors between medication and lifestyle adherence that 
were just not assessed.
In light of the fact that medication and lifestyle adherence did not correlate, the 
two stepwise regression models also lend support that predictors for one type of 
adherence may be different compared to the other type of adherence. Further research 
should more explicitly evaluate the extent to which predictors are differentially related to 
medication and lifestyle adherence. It would prove useful for physicians and health care 
providers to be aware that not only is lifestyle and medication adherence different 
constructs but predictors for one may be different than for the other type of adherence
As indicated above, this analysis used the CSM as a theoretical guide; however 
another model that has had considerable attention in hypertension adherence research is 
the Health Belief Model (HBM).
“The HBM is essentially a utility model. Its’ perspective on adherence is that 
motivation emerges if an individual believes they are susceptible to a condition 
and that the condition is severe. Thus, individuals are motivated to avoid a health 
threat if the threat is believed likely (high probability of occurrence) and is seen to 
have a negative impact on function or life itself (high severity). The specific 
action selected depends upon its perceived benefits, access, likelihood of reducing 
threat) and costs (actual financial cost; side effects; negative views of action by 
family and friends, etc.). In addition, the concept of triggers to perceptions of 
vulnerability and severity, e.g., symptoms, observation of illness in proximal
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others, etc., was added to HBM in 1957” (Rosenstock, Hochbaum & Leventhal, 
I960 ) . 1
For additional review on the HBM please see Ogden (2007).
Middleton (2009) used the HBM framework and suggests that African 
Americans do not adhere to hypertension treatments because the understandings of lay 
beliefs diverge from the medical knowledge. For example, individuals believe they are 
not susceptible and consider the condition to not be serious. As an extension of 
Middelton’s (2009) work, Brown and Segal (1996) found that temporal-orientation has an 
effect on HBM’s susceptibility and medication beliefs. More specifically, African 
Americans compared to White Americans were more likely to be present-oriented which 
affected management of hypertension. Present-oriented individuals compared to future- 
orientated individuals considered themselves to be less susceptible to the outcomes of 
hypertension, believed in the efficacy of home remedies, and believed less in the efficacy 
of prescription medications.
The HBM has also been used to exclusively evaluate medication adherence in 
hypertensive patients. Hershey and colleagues (1980) used self-report to determine the 
extent to which medication compliance was related to the HBM components. There was a 
significant positive relationship with blood pressure and reported medication adherence 
when compliance was dichotomized between reporting not missing a dose of their 
medications and missing some of their pills. The researchers also found that three 
(“control over health matters, perceived barriers, and duration of treatment”) of the five
1 The following section was prepared from a personal interview with H. Leventhal, an 
originator of HBM and close associate and colleague of Rosenstock, Hochbaum and 
Becker. (May 6, 2010)
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variables (“perceived severity and perceived benefits”) that contribute to the make up the 
HBM relate to medication adherence, independently.
When considering the HBM and the CSM it is important to note that the HBM 
and the CSM are not contradictions of one another. The CSM was developed as an 
extension of the HBM.
“Both models consider patient beliefs as the driving force for behavior. However, 
with the exception of the “triggers” concept the variables in HBM are highly 
abstract (beliefs), stated as probabilities (likelihood of occurrence) and utilities 
(severity) and attend less to the factors that underlie and represent the experiential 
basis of these variables. The shift away from experience based perceptions 
(perceived triggers, symptoms and observations of illness in others) and perceived 
utilities (felt and observed changes in function, symptoms (pain) and cognitive 
and social activities) to probability and severity judgments occurred as 
investigators using HBM moved toward large scale survey research abandoning 
open ended questions. This shift was subtle, a source of contention with the 
original core of HBM investigators but solidified when the core empirical work 
was taken in hand by Dr. Marshall Becker, a highly competent medical 
sociologist. At a later date, HBM assimilated concepts from social learning 
theory (self efficacy) to improve its predictive power. The differences between 
HBM and CSM are primarily in the degree to which their measures focus on the 
abstract aspect of representations of illness threats and treatments versus the 
experiential basis of these abstractions, i.e., the perception, actual performance, 
and perception of outcomes, HBM tending to focus on the abstract features and
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CSM on the experiential. The relative predictive power of these two levels of the 
same constructs will vary by context, i.e., the illness (the degree to which it is
symptomatic and impacts function), the treatment and the patient population
2(verbal/conceptual fluency versus grounded in everyday experience)”.
“cure in HBM is the belief that the disease is no more, cure in CSM means I no 
longer experience the symptoms and dysfunction of the disease AND (because of 
that) believe that the disease is gone.”
The hypotheses of this study were confirmed and the goal of the study was 
attained, for it has provided a step toward much needed research that exclusively 
evaluates the extent to which medication and lifestyle adherence are not related and 
predictors for one are different from predictors for the other. This might affect patient 
management of hypertension.
This study was intended to be a beginning in evaluating how hypertension 
patients manage their chronic condition and to explicitly evaluate medication and 
lifestyle adherence, which have been to shown to be important to hypertension 
management (Appel et al., 2006). This study is however, exploratory and as such there 
are a number of limitations which may account for the inconclusive findings. Taking into 
consideration that this study was from a larger research project, the focus was on patient
2 The following section was prepared from a personal interview with H. Leventhal, an 
originator of HBM and close associate and colleague of Rosenstock, Hochbaum and 
Becker. (May 6,2010)
3 The following section was prepared from a personal interview with H. Leventhal, an 
originator of HBM and close associate and colleague of Rosenstock, Hochbaum and 
Becker. (May 6, 2010)
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management and resolution of their (the patient’s) presenting complaint. Thus, patients 
could have had any number of ailments that were the focus of the interview, therefore not 
responding to the inquiries in terms of their hypertension. Additionally, the hypertension 
questions were administered at the end of the interview and may have been subject to 
patient fatigue. Finally, the sample size was relatively small. Many of the constructs 
measured were assessed based upon single items which do not allow for generalizability 
as well as meaningful interpretations.
In order to gain insight into how patients manage their hypertension it would be 
ideal to have a study that exclusively researches hypertension management and the 
evaluation of lifestyle as well as medication adherence as separate constructs. As 
elaborated previously, medication adherence is particularly low when patients admit to 
missing a single dose (60%) (Haynes, McDonald, & Garg, 2002). Additionally, lifestyle 
adherence is low for a multitude of reasons including intention-behavior gap, preference 
reversals, conservation of energy in the elderly, and ratings of self assessed health 
(Sniehotta, Scholz, & Schwarzer, 2005; Bems, Laibson, & Loewenstein, 2007; Duke et 
al., 2002; and Idler, Leventhal, McLaughlin, & Leventhal, 2004). In designing a better 
study it would be imperative to have more items that assess the predictors as well as 
lifestyle and medication adherence more fully. For example, it would be beneficial to 
evaluate diet and exercise adherence separately. Perhaps the inconclusive findings in the 
present study were a function of the combined item which was used to evaluate lifestyle 
adherence (“Do you ever accidentally forget to do one of your other treatments (diet, 
exercise, or others)?”). The evaluation of CSM-related predictors should have multiple 
measures. For example, monitoring behavior has shown a positive relationship with
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medication adherence (Feldman et al., 1998). Our null results may be due in part because 
of the single item that was used. It would be beneficial to use multiple items that assess 
blood pressure monitoring including blood pressure from the doctor’s office and blood 
pressure from those patients who do monitor themselves.
Additionally, a focus group of hypertension patients would be useful to add 
qualitative data and to test the extent to which each item measures what is desired. In 
order to more fully tap into patient’s adherence beliefs and behaviors it would be 
beneficial to use the same items as Hekler and colleagues (2008) did. As Leventhal and 
Cameron (1987) posit, a critical component in patient adherence is patient beliefs. 
Additionally, the experiential factors are important to consider when evaluating 
adherence. Assessing patients CSM beliefs can also assist health care providers and 
doctors in understanding patient adherence. The evaluation of each CSM domain 
(identity, consequence, cure, cause, and control) is important to explore especially as 
each domain relates to medication and lifestyle adherence.
A useful instrument is the Illness Perception Questionnaire (IPQ-R) which was 
derived from the CSM and addresses each of the five-domains (Moss-Morris R., 
Weinman J., Petrie K.J., Home R., Cameron L.D., & Buick D., 2002). Findings would 
have theoretical relevance as well as applicability for physicians and health care 
providers. Lastly, funding permitting, it would be beneficial to implement a longitudinal 
design in order to evaluate the extent to which beliefs and behaviors change as related to 
the CSM over time (Interpretation, Coping and Appraisal stage).
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Table 1
CSM predicted correlations for hypothesis one and two 
Predicted correlations
Medication adherence Lifestyle adherence
Monitoring behavior 
(use of blood pressure cuff)
+ ?
Self Assessed Health (SAH) + +
Condition-worry + ?
Physical functioning + +
CSM Timeline belief + ?
CSM control belief 
Medication beliefs:
+ ?
The prescribed treatment 
for my hypertension 
keeps it under good control.
+ ?
I can actually feel the medicines 
working in my body.
+ ?
The side effects of this treatment 
are manageable for me.
+ ?





Characteristics of the Processes of Illness Management (PRIM) hypertension patients 
Descriptives of hypertension patients (n=105)
Age (years), mean ± SD 66.68±12.06
Female (%) 64.8%
Education < 2 year university 
degree (associate degree) (%)
49.5%
Employment Retired: 54.3%
Working full time: 28.6% 
Working part time: 7.9% 
Disabled/on disability: 7.9% 
Homemaker: 1.9%





Medicare w/supplemental insurance: 46.2%





Black/African American: 19% 





Pearson Correlation Coefficient of predictors and medication/lifestyle adherence 
Comparisons between medication and lifestyle adherence
Predictors
(df)
Medication adherence (df) Lifestyle adherence
Monitoring behavior -.130(102) .067(102)
Self Assessed health -.014(103) .222*(103)
Condition worry -.168(102) -.197*(102)
Physical functioning .152(103) .024(103)
Hypertension duration belief .039(97) -.059(97)
Hypertension control belief .121(102) .141(102
Medication belief:
The prescribed treatment for my 
Hypertension keeps it under good 
control.
.021(101) .224*(101)
I can actually feel the medicines 
working in my body.
-.135(101) .109(101)
The side effects of this treatment 
are manageable for me.
.232*(95) .053(95)






Estimated coefficients from OLS stepwise regression of medication adherence by patient 
predictors from the Rutgers University PRIM study.
Standard
Model Coefficient Error Beta t-
statistic
“The side effects of this treatment are -.205 .088 -.257 -2.317
manageable for me”
Constant 2.778* 0.406 6.850
Adj RA2 0.054
Source: Rutgers University, CSHBB PRIM study (2007-2008)
NOTE: N=77; Coefficient b =unstandardized regression coefficient. *p<.05
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Table 4.1
Estimated coefficients from OLS stepwise regression of medication adherence by patient 
non- significant predictors from the Rutgers University PRIM study.
Model t-statistic Sig Beta
Age 1.113 .269 .123
Education
001 .875 -.018
Race 1.273 .207 .141
Monitor behavior 1.276 .206 .141
Self Rated Health .662 .510 .074
Condition-worry 1.009 .316 .116
Physical Functioning -1.936 .057 -.211
Duration hypertension belief -.351 .727 -.039
Control hypertension belief -.199 .843 -.024
“The prescribed treatment for my 
Hypertension keeps it under good control”
.416 .678 .049
“I can actually feel the medicines working 
in my body”
1.178 .243 .130
“I have a good idea how the medicines work”.837 .405 .094
Source: Rutgers University, CSHBB PRIM study (2007-2008), NOTE: N=77; Beta In = 
beta weight that would result if variable/item were entered back into the mode
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Table 5
Estimated coefficients from OLS stepwise regression of lifestyle adherence by patient 
predictors from the Rutgers University PRIM study.
Standard
Model Coefficient Error Beta t-
statistic
“The prescribed treatment for my -.369 .170 -.241 -2.170
hypertension keeps in under good control”
Constant 4.274* 0.763 5.603
Adj RA2 0.046
Source: Rutgers University, CSHBB PRIM study (2007-2008)
NOTE: N=77; Coefficient b =unstandardized regression coefficient. *p<.05
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Table 5.1
Estimated coefficients from OLS stepwise regression of lifestyle adherence by patient 
non- significant predictors from the Rutgers University PRIM study.
Model t-statistic Sig Beta In
Age -1.412 .162 -.157
Education 1.527 .131 .170
Race -.183 .855 -.021
Monitor behavior -1.472 .145 -.163
Self Rated Health -.790 .432 -.095
Condition-worry .528 .599 .066
Physical Functioning .798 .428 .093
Duration hypertension belief .232 .817 .026
Control hypertension belief .495 .622 .077
“I can actually feel the medicines working 
in my body”
-1.661 .101 -.184
“The side effects of this treatment are 
manageable for me”
.397 .692 .047
“I have a good idea how the medicines work Is*
 
H
-k 00 .059 -.211
Source: Rutgers University, CSHBB PRIM study (2007-2008), NOTE: N=77; Beta In = 
beta weight that would result if variable/item were entered back into the model.
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Variable Survey Question Possible choices
Medication “do you ever accidently forget to use one 






“do you ever accidently forget to do one of your “never,” “rarely,”
other treatments (diet, exercise, or other)? “sometimes,” “often”
or “always”
Monitoring “how often do use a monitor or instrument 
Behavior to keep track of your hypertension?
“not at all,” “less than 
Once a month,” 
“monthly,” “weekly 





“in general, would you say your health is:” “poor,” “fair,” “good” 
“very good,” 
“excellent”
Condition-worry “how worried or concerned are you about 
Your hypertension?”
Physical SF-12 composite of:
Functioning “does your health now limit you in moderate 
activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing gold?” 
“does your health now limit you in climbing 
several flights of stairs?”
“not at all,” “a little 
bit,” “somewhat,” 
“quite a bit,” or 
“very much”
“yes, limited a lot,” 
“yes, limited a little,” 
“no, not limited at all”
CSM Beliefs “I will have hypertension for the rest of my life?
‘My hypertension is under control most or
“not at all,” “ a little 
bit," “somewhat,” 
“quite a bit” or 
“very much” 
not at all,” “a little bit,” 
somewhat,” “quite a bit,” or 
very much”
Appendix 1 (continued)
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Variable Survey Question Possible choices
Medication belief “the prescribed treatment for my hypertension “not at all,”
keeps it under good control” “a little bit” 
“somewhat” 
“quite a bit,” 
“very much”
“I can actually feel the medicines working in 
my body.”
“not at all,” “a little 
bit,” “somewhat,” 
“quite a bit,” or 
“very much”
“the side effects of this treatment are 
manageable for me.”
“not at all,” “a little 
bit,” “somewhat” 
“quite a bit,” or 
“very much”
“I have a good idea of how the medicines 
work.”
“not at all,” “ a little 
bit,” “somewhat,” 
“quite a bit,” or 
“very much”
Age What is your age? Patient’s Age
Education What is your highest degree from school? Primary; High school; 




Race What race do you identify most with? White, Black/Afiican 
American, Asian/ 
Pacific Islander, 
Other
